Go to industries

Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
Worldwide
472
deals closed in Healthcare
Worldwide
Explore all our industry-related deals
Go to deals
Sopharma Group has acquired two pharmaceutical products in Poland
Healthcare

Sopharma Group has acquired two pharmaceutical products in Poland

Sopharma Group has acquired Coffepirine and Kopiryna, two highly recognized medicines to treat headache. The acquisition will further expand the market presence of Sopharma Group in the Polish market and support the promising potential of the two pharmaceutical drugs.

Learn more
Sopharma has agreed to acquire Pharmanova, a Serbian-based pharmaceutical company
Healthcare

Sopharma has agreed to acquire Pharmanova, a Serbian-based pharmaceutical company

Sopharma has signed a contract for the phased acquisition of the Serbian-based pharmaceutical manufacturer Pharmanova. The deal is structured in three steps, starting with the acquisition of 25% interest in December 2023, which is increased to 75% in 2024 and to 100% in 2025. With this transaction, Sopharma will further strengthen its market position in the Balkans and add to its family of businesses one of the biggest producers of branded herbal medicines and dietary products in Serbia.

Learn more
SAT Health expands its outpatient care by acquiring Blocks Medical Center
Private Equity | Healthcare

SAT Health expands its outpatient care by acquiring Blocks Medical Center

Blocks Health and Social Care has sold Blocks Medical Center Mladost to SAT Health, a private equity-backed healthcare data analytics and outpatient care provider.

Learn more
“During the last 12 years, I have made move UP what it is today, a valued partner in physical fitness for health insurers and employers. Acture shares my vision of physical health. I look forward to developing the concept of total welfare management together with Acture in Germany and the rest of Europe. I want to express my heartfelt gratitude to the Oaklins team, our invaluable partner throughout this process. Their unwavering dedication and strategic guidance played a pivotal role in navigating the complexities of this deal and we sincerely appreciate their substantial operational support. We are confident and ready to embrace a prosperous future as an integral part of the Acture family.”

Jan-Frederik Kolthoff

Founder and CEO, move UP Gesellschaft für Gesundheitsmanagement mbH

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=BG&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Belgian radioisotope producer secures US$104.1 million to expand global production

DEAL FLASH: PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Oaklins’ team in Belgium acted as the sole financial advisor in this transaction.

Learn more

Talk to our local advisors

Nasko Jordanov

Principal
Sofia, Bulgaria
Oaklins Karoll

Meet our global industry specialists

Antoine Lemaire

Partner
Paris, France
Oaklins France

Robert Boersma

Partner
Amsterdam, Netherlands
Oaklins Netherlands

Stuart Goodman

Partner
London, United Kingdom
Oaklins Evelyn Partners

Michael Jewell

Partner
London, United Kingdom
Oaklins Cavendish

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital